homeostasis/metabolism
• mice exhibit an increase in serum vasopressin levels compared with wild-type mice
• however, treatment with propranolol restores normal levels
|
• mice exhibit an increase in serum noradrenaline levels compared with wild-type mice
• however, treatment with captopril and propranolol restores normal levels
|
• mice exhibit reduced bradykinin serum concentration compared with wild-type mice
|
• treatment with captopril prevents alterations in angiotensin II, bradykinin, and noradrenaline levels, up-regulation catecholamines, cardiovascular remodeling, and tissue fibrosis
• treatment with losartan reduces blood pressure to levels similar to in wild-type mice
• treatment with propranolol blocks hypertension, tachycardia, cardiovascular remodeling, restores vasopressin, angiotensin II, and aldosterone plasma levels, and heart and renal fibrosis
• however, bosentan exhibits no effect on mice
|
cardiovascular system
• mice exhibit a severe thickening of the aorta media wall due to increased numbers of smooth muscle cells and high levels of deposition of extracellular matrix
|
• mice exhibit a severe thickening of the aorta media wall due to increased numbers of smooth muscle cells and high levels of deposition of extracellular matrix unlike in wild-type mice
|
• mice exhibit cardiac defects beginning at 4 months that become more accentuated in older mice unlike in wild-type mice
• however, treatment with captopril or propranolol prevents cardiac remodeling
|
• cardiomyocyte hypertrophy
|
• mice exhibit cardiac fibrosis in the left ventricle unlike in wild-type mice
• however, treatment with captopril or propranolol prevents fibrosis
|
• whether anesthetized or awake
|
hypertension
(
J:124056
)
• whether anesthetized or awake, mice exhibit hypertension compared with wild-type mice
• however, treatment with losartan or propranolol blocks hypertension
|
immune system
• in response to BCR stimulation
|
• the number of IgMloIgDhi B cells is reduced in the lymph nodes compared to in wild-type mice
|
• reduced 80%
|
• in response to primary immunization or re-immunization with DNP-KLH
|
• in response to primary immunization or re-immunization with DNP-KLH
|
• mice produce less than normal IgG3 in response to immunization with DNP-ficoll or DNP-KLH
• however, IgG3 production in response to immunization with DNP-KLH is normal
|
• mice produce less than normal IgM in response to immunization with DNP-ficoll
• however, IgM production in response to immunization with DNP-KLH is normal
|
renal/urinary system
• mice exhibit renal fibrosis in the left ventricle unlike in wild-type mice
• however, treatment with captopril or propranolol prevents fibrosis
|
endocrine/exocrine glands
• medulla cells are hyper-activated and contain fewer catecholamine-containing vesicles compared with wild-type cells
|
muscle
• mice exhibit a severe thickening of the aorta media wall due to increased numbers of smooth muscle cells and high levels of deposition of extracellular matrix unlike in wild-type mice
|
• cardiomyocyte hypertrophy
|
nervous system
hydrocephaly
(
J:124056
)
hematopoietic system
• in response to BCR stimulation
|
• the number of IgMloIgDhi B cells is reduced in the lymph nodes compared to in wild-type mice
|
• reduced 80%
|
• in response to primary immunization or re-immunization with DNP-KLH
|
• in response to primary immunization or re-immunization with DNP-KLH
|
• mice produce less than normal IgG3 in response to immunization with DNP-ficoll or DNP-KLH
• however, IgG3 production in response to immunization with DNP-KLH is normal
|
• mice produce less than normal IgM in response to immunization with DNP-ficoll
• however, IgM production in response to immunization with DNP-KLH is normal
|
growth/size/body
cellular
• in response to BCR stimulation
|